share_log

Organigram Q4 Revenue Grows 83% YoY, Provides Outlook

Organigram Q4 Revenue Grows 83% YoY, Provides Outlook

OrganiGram第四季度收入同比增長83%,提供展望
Benzinga Real-time News ·  2022/11/29 07:56
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) released its results for the fourth quarter and year ended August 31, 2022, revealing net revenue in FY 2022 increased 84% to $145.8 million from $79.2 million in the previous year primarily due to an increase in recreational and international revenue, partially offset by a decrease in medical sales.
OrganiGram Holdings Inc.納斯達克(TSX:OGI)(多倫多證券交易所股票代碼:OGI)發佈了截至2022年8月31日的第四季度和年度業績,披露淨收入在2022財年增長84%,達到1.458億美元這主要是由於娛樂和國際收入增加,但部分被醫療銷售額的下降所抵消。
Q4 and Fiscal 2022 Financial Highlights
第四季度和2022財年財務亮點
Net revenue increased 83% to $45.5 million in Q4 2022, from $24.9 million in Q4 fiscal 2021. Gross margin before fair value changes to biological assets, inventories sold, and other charges:
2022年第四季度淨收入增長83%,從2021財年第四季度的2490萬美元增至4550萬美元。 生物資產、出售的存貨和其他費用的公允價值變動前的毛利率:
Q4 fiscal 2022 margin improved to $8.8 million from negative $1.0 million in Q4 fiscal 2021. In fiscal 2022, margin improved to $26.8 million from negative $24.4 million in fiscal 2021. Adjusted...
2022財年第四季度利潤率從2021財年第四...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論